Endurant Capital Management as of Dec. 31, 2020
Portfolio Holdings for Endurant Capital Management
Endurant Capital Management holds 52 positions in its portfolio as reported in the December 2020 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Oxford Immunotec Global Ord Shs | 14.1 | $39M | 2.2M | 17.46 | |
| Becton, Dickinson and (BDX) | 6.3 | $17M | 69k | 250.22 | |
| Bristol Myers Squibb (BMY) | 5.5 | $15M | 244k | 62.03 | |
| Trillium Therapeutics Com New | 3.5 | $9.6M | 656k | 14.71 | |
| Abbvie (ABBV) | 3.3 | $9.1M | 85k | 107.15 | |
| Johnson & Johnson (JNJ) | 3.2 | $8.9M | 56k | 157.39 | |
| Orthopediatrics Corp. (KIDS) | 2.9 | $8.0M | 193k | 41.25 | |
| AmerisourceBergen (COR) | 2.8 | $7.7M | 78k | 97.75 | |
| Si-bone (SIBN) | 2.7 | $7.6M | 255k | 29.90 | |
| Smith & Nephew Spdn Adr New (SNN) | 2.7 | $7.6M | 179k | 42.17 | |
| Aclaris Therapeutics (ACRS) | 2.6 | $7.3M | 1.1M | 6.47 | |
| Anthem (ELV) | 2.6 | $7.3M | 23k | 321.11 | |
| Syneos Health Cl A | 2.5 | $6.9M | 102k | 68.13 | |
| Molecular Templates | 2.3 | $6.4M | 681k | 9.39 | |
| Fate Therapeutics (FATE) | 2.2 | $6.1M | 67k | 90.94 | |
| Encompass Health Corp (EHC) | 2.2 | $6.0M | 73k | 82.69 | |
| Ocular Therapeutix (OCUL) | 2.2 | $6.0M | 291k | 20.70 | |
| Adaptimmune Therapeutics Sponds Adr (ADAP) | 2.1 | $5.8M | 1.1M | 5.39 | |
| Adapthealth Corp Com Cl A (AHCO) | 2.0 | $5.7M | 150k | 37.56 | |
| Aziyo Biologics Com Cl A (ELUT) | 2.0 | $5.6M | 408k | 13.63 | |
| Owens & Minor (OMI) | 2.0 | $5.5M | 204k | 27.05 | |
| Avantor (AVTR) | 2.0 | $5.5M | 195k | 28.15 | |
| Esperion Therapeutics (ESPR) | 1.9 | $5.4M | 207k | 26.00 | |
| Cigna Corp (CI) | 1.9 | $5.2M | 25k | 208.17 | |
| Sarepta Therapeutics (SRPT) | 1.7 | $4.8M | 28k | 170.48 | |
| Insmed Com Par $.01 (INSM) | 1.5 | $4.1M | 124k | 33.29 | |
| Laboratory Corp Amer Hldgs Com New (LH) | 1.5 | $4.0M | 20k | 203.54 | |
| Sutro Biopharma (STRO) | 1.3 | $3.7M | 172k | 21.71 | |
| Mustang Bio | 1.2 | $3.4M | 892k | 3.78 | |
| Goodrx Hldgs Com Cl A (GDRX) | 1.1 | $3.1M | 77k | 40.33 | |
| Humana (HUM) | 1.1 | $3.1M | 7.5k | 410.31 | |
| Selecta Biosciences (RNAC) | 1.1 | $3.0M | 991k | 3.03 | |
| Astrazeneca Sponsored Adr (AZN) | 1.0 | $2.8M | 57k | 49.99 | |
| AngioDynamics (ANGO) | 1.0 | $2.8M | 185k | 15.33 | |
| Pra Health Sciences | 1.0 | $2.7M | 22k | 125.43 | |
| Iovance Biotherapeutics (IOVA) | 0.9 | $2.5M | 54k | 46.40 | |
| Kiniksa Pharmaceuticals Com Cl A (KNSA) | 0.9 | $2.4M | 134k | 17.67 | |
| Centene Corporation (CNC) | 0.8 | $2.3M | 38k | 60.03 | |
| Immunic (IMUX) | 0.8 | $2.1M | 139k | 15.29 | |
| Zoetis Cl A (ZTS) | 0.8 | $2.1M | 13k | 165.47 | |
| Aptose Biosciences Com New | 0.8 | $2.1M | 478k | 4.38 | |
| Eucrates Biomedical Acqu Cor Unit 10/23/2027 | 0.7 | $2.1M | 195k | 10.66 | |
| Prothena Corp SHS (PRTA) | 0.7 | $1.8M | 152k | 12.01 | |
| Albireo Pharma | 0.6 | $1.6M | 42k | 37.50 | |
| Merck & Co (MRK) | 0.4 | $1.2M | 15k | 81.77 | |
| Quotient SHS | 0.4 | $1.2M | 227k | 5.21 | |
| Pennant Group (PNTG) | 0.4 | $1.1M | 18k | 58.05 | |
| Medavail Holdings Ord | 0.3 | $955k | 64k | 15.05 | |
| Senseonics Hldgs Note 5.250% 2/0 | 0.2 | $638k | 1.5M | 0.43 | |
| Akari Therapeutics Sponsored Adr | 0.1 | $382k | 207k | 1.85 | |
| Solid Biosciences | 0.1 | $346k | 46k | 7.57 | |
| F-star Therapeutics | 0.1 | $202k | 20k | 9.88 |
